Cronos Group

German court hits brakes on medical cannabis cultivation plan

A German court slammed the brakes on the country’s plan to grant contracts to cultivate medical marijuana, giving international exporters an even bigger head start over domestic production as the country struggles to meet MMJ demand.

A representative for the Higher Regional Court of Dusseldorf told Marijuana Business Daily that the Federal Institute for Drugs and Medical Devices (BfArM) is not allowed to appeal the decision.

Read More

Australian state to investigate legalizing recreational cannabis

Australia’s second-most populous state will explore international developments around “cannabis for adult use” as part of its investigation into drug law reform. In a 586-page report, a parliamentary committee in Victoria recommended the creation of a council to investigate global changes in marijuana usage, as well as several other considerations involving comprehensive drug law reform. […]

Read More

Week in Review: MedMen-Cronos alliance, California MJ business licensing & Arkansas’ MMJ woes

MedMen strikes up a cannabis partnership with Canada’s Cronos Group, California’s Humboldt County considers reopening its licensing process, and a judge tells Arkansas to stop issuing medical marijuana licenses. Here’s a closer look at some notable developments in the marijuana industry over the past week. Brave new world? Multistate cannabis giant MedMen’s collaboration with a […]

Read More

MedReleaf signs deal to supply medical marijuana to German distributor

A top Canadian medical cannabis producer signed a deal to become the largest supplier of medical marijuana products to a pharmaceutical distributor in Germany. MedReleaf, based in Markham, Ontario, and listed as LEAF on the Toronto Stock Exchange, expects shipments to Cannamedical Pharma GMBH to commence in the coming weeks, according to a news release from the company. […]

Read More

US marijuana retail chain MedMen to partner with Canadian producer Cronos

Two major cannabis companies – Los Angeles-based MedMen and Ontario-based Cronos Group – have announced a joint venture to bring MedMen’s retail expertise to Canada. According to a news release, the collaboration will result in the formation of MedMen Canada. MedMen currently has operations in California, Nevada and New York; Cronos has concerns throughout Canada […]

Read More

Germany’s medical marijuana market poised for breakout year

Germany is on track to become one of the world’s largest medical marijuana markets this year as insured patient numbers soar, MMJ imports rise and the country prepares for domestic cultivation. Some executives also expect recreational legalization to happen “in the foreseeable future.” Germany’s rapid growth is expected to continue independent of the country’s plan […]

Read More

Cronos lists on Nasdaq, as US gets first ‘pure play’ marijuana stock on major exchange

A Canadian marijuana company will become the first “pure play” cannabis listing on a major U.S. stock market, an important milestone for the cannabis industry.

Cronos Group, one of Canada’s largest vertically integrated medical marijuana companies, will start trading Tuesday on the Nasdaq Global Market under the symbol CRON. Cronos will maintain its listing on Toronto’s TSX Venture Exchange.

Read More

Marijuana industry goes to court to force Israeli government to permit MMJ exports

The marijuana industry is fighting a high-stakes court battle to force the Israeli government to approve medical cannabis exports sooner rather than later. The decision by industry advocates to go to court comes as Israeli lawmakers prepare to debate the country’s medical cannabis export policy on Monday. The outcome is huge for dozens of international […]

Read More

Israel hits pause on medical marijuana exports; Cronos exec not concerned 

Israel Prime Minister Benjamin Netanyahu has suspended reforms on plans to allow cannabis growers to export their product due to concerns that MMJ could find its way to the black market. One Canadian company that expanded to Israel last year, Stayner, Ontario-based Cronos Group, said the regulatory delay doesn’t change its strategy, and the licensed producer still aims […]

Read More

‘Launchpad to Asia’: Cronos pulls veil off Australian joint venture

Cronos Group unveiled its Australian joint venture and the first phase of a 10-million-Australian-dollar ($8 million) production facility, the latest move by a Canadian company to carve out opportunities to meet demand Down Under and position itself to capitalize on future possibilities in Asia. It’s the first Canadian company to help build a medical cannabis company in Australia […]

Read More